Pharmaceutical

Setback for UK pharma as government sets unexpectedly high VPAG payback rate in 2025

The UK's DHSC has announced its anticipated 2025 headline payback rate for new medicines under the 2024–2028 VPAG.

Dec 21, 2024 - 06:00
Setback for UK pharma as government sets unexpectedly high VPAG payback rate in 2025
The UK's DHSC has announced its anticipated 2025 headline payback rate for new medicines under the 2024–2028 VPAG.
Read the original article

Tags:

Previous Article

FDA confirms end of Eli Lilly’s tirzepatide shortage after re-evaluation

Next Article

Palleon and Shanghai Henlius Biotech link on autoimmune therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: With new study data, Intra-Cellular could expand use of approved mood-disorder treatment

STAT+: With new study data, Intra-Cellular could expand...

Mar 28, 2023

iOnctura expands PI3K inhibitor programme to NSCLC

iOnctura expands PI3K inhibitor programme to NSCLC

Jul 10, 2024

Food companies to regulators: Please don’t worry about ultra-processed anything

Food companies to regulators: Please don’t worry about ...

Sep 12, 2023